A novel suicide gene therapy approach for reduction of GvHD using lentiviral 
delivery of a modified human thymidylate monophosphate kinase

Sato, T.; Neschadim, A.; Rasaiah, V.; Konrad, M.; Fowler, D. H.; Lavie, A.; Medin, J. A.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Conference Paper

A novel suicide gene therapy approach for reduction of GvHD using lentiviral delivery of a modified human thymidylate monophosphate kinase

MPS-Authors

/persons/resource/persons15362

Konrad, M.
Research Group of Enzyme Biochemistry, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Sato, T., Neschadim, A., Rasaiah, V., Konrad, M., Fowler, D. H., Lavie, A., et al. (2005). A novel suicide gene therapy approach for reduction of GvHD using lentiviral delivery of a modified human thymidylate monophosphate kinase. Blood, 106(11), 397B-397B.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-E78B-6

Abstract

There is no abstract available